Tags Biomedical
Related Insights
Thu 08 Sep 2022
Case Study: AI & phenotypic assays for target identification
Discover how Kantify and I-Stem have combined artificial intelligence and phenotypic assays to perform unbiased target identification in a short timeframe
Thu 12 Aug 2021
AI for Breast Cancer Detection using whole-slide images
Step-by-step approach from data selection, cleaning and augmentation to training of a deep neural network for segmenting whole-slide images and counting nuclei.
Thu 17 Jun 2021
Diagnosing Endometrial Diseases from Tissue Images using AI
Discover how Artificial Intelligence can help diagnose endometrial diseases from tissue images
Fri 19 Mar 2021
ZeptoNet White Paper: AI for drug discovery
We present ZeptoNet, our novel machine learning technology for in silico small molecule screening at scale
Related News
Mon 28 Mar 2022
Kantify at the annual event of Brussels' Healthtech cluster
Kantify is speaking at the annual event of the Brussels cluster of healthtech companies
Thu 30 Sep 2021
European Biotech Week: webinar on AI for Drug Discovery
Kantify hosted its first webinar titled Artificial Intelligence for Drug Discovery and Development, as a part of the European Biotechnology Week 2021
Thu 22 Jul 2021
Kantify joins the European Biotechnology Network
Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences
Mon 10 May 2021
Kantify joins Data-driven Advanced Therapeutics Accelerator
Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst
Wed 14 Apr 2021
The CEO of Kantify interviews with DataNews
The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry
Fri 19 Mar 2021
Kantify announces its new drug discovery technology
Kantify announces ZeptoNet, its new Virtual screening technology of small molecules
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.